Chiron Capital Management LLC Acquires 3,000 Shares of Humana Inc. $HUM

Key Points

• Chiron Capital Management LLC increased its stake in Humana Inc. by 99.9% in Q1, now holding 6,003 shares valued at approximately $1.58 million.
• Humana announced a quarterly dividend of $0.885 per share, representing a yield of 1.2%, with the payment date set for October 31st.
• Humana's earnings missed estimates for the last quarter, reporting $6.27 EPS compared to the expected $6.32, but had a revenue of $32.39 billion, exceeding projections.

Chiron Capital Management LLC lifted its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 99.9% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 6,003 shares of the insurance provider's stock after purchasing an additional 3,000 shares during the period. Humana comprises about 1.4% of Chiron Capital Management LLC's investment portfolio, making the stock its 16th biggest holding. Chiron Capital Management LLC's holdings in Humana were worth $1,588,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of HUM. Cary Street Partners Investment Advisory LLC increased its holdings in shares of Humana by 63.9% in the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock valued at $31,000 after acquiring an additional 46 shares during the last quarter. Riverview Trust Co bought a new stake in Humana during the first quarter valued at $34,000. Garde Capital Inc. bought a new position in shares of Humana in the 1st quarter worth about $36,000. Zions Bancorporation National Association UT bought a new position in shares of Humana in the 1st quarter worth about $37,000. Finally, Whipplewood Advisors LLC boosted its holdings in shares of Humana by 639.1% in the 1st quarter. Whipplewood Advisors LLC now owns 170 shares of the insurance provider's stock valued at $45,000 after buying an additional 147 shares during the period. 92.38% of the stock is owned by institutional investors.

Humana Trading Down 1.3%

HUM traded down $4.07 during trading on Friday, reaching $307.94. The company had a trading volume of 1,504,536 shares, compared to its average volume of 1,704,650. The firm's 50-day simple moving average is $260.14 and its 200 day simple moving average is $256.12. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. The company has a market cap of $37.04 billion, a price-to-earnings ratio of 23.63, a PEG ratio of 1.83 and a beta of 0.44. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $369.17.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). The firm had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. Humana's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period last year, the firm earned $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. Equities research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.1%. The ex-dividend date is Friday, September 26th. Humana's dividend payout ratio is presently 27.17%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Sanford C. Bernstein upped their price objective on Humana from $269.00 to $341.00 and gave the stock an "outperform" rating in a research note on Friday. Royal Bank Of Canada upped their price target on shares of Humana from $283.00 to $322.00 and gave the stock an "outperform" rating in a research report on Thursday, August 21st. Piper Sandler cut their price objective on shares of Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a research report on Thursday, July 31st. Wall Street Zen lowered shares of Humana from a "buy" rating to a "hold" rating in a research note on Saturday, August 2nd. Finally, Wells Fargo & Company decreased their price objective on Humana from $348.00 to $344.00 and set an "overweight" rating for the company in a report on Thursday, August 14th. Seven equities research analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $289.24.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.